Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| G1 Execution Services, LLC | DAVE Dave Inc. | 13G | 5.4% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | ONCH 1RT Acquisition Corp. | 13G/A | 9.88% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | REXR Rexford Industrial Realty, Inc. | 13G/A | 12.6% | Mar 31, 2026 | 6mo |
| EMINENCE CAPITAL, LP | LPX Louisiana-Pacific Corp | 13G/A | 3.6% | Mar 31, 2026 | 6mo |
| Cormorant Asset Management, LP | CABA Cabaletta Bio, Inc. | 13G/A | 9.03% | Mar 31, 2026 | 6mo |
| AQR CAPITAL MANAGEMENT LLC | LYFT Lyft, Inc. | 13G/A | 2.98% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | SPRB Spruce Biosciences, Inc. | 13G/A | 3.6% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | CCS Century Communities, Inc. | 13G/A | 3.1% | Mar 31, 2026 | 6mo |
| Jabbok Schlacks | EQPT EquipmentShare.com Inc | 13G | 14.9% | Mar 31, 2026 | 6mo |
| Vestal Point Capital, LP | DRUG Bright Minds Biosciences Inc. | 13G | 5% | Mar 31, 2026 | 6mo |
| Scott Farquhar | TEAM Atlassian Corp | 13G/A | 22.7% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | SHAK Shake Shack Inc. | 13G/A | 4.3% | Mar 31, 2026 | 6mo |
| Atreides Management, LP | ACVA ACV Auctions Inc. | 13G/A | 5.6% | Mar 31, 2026 | 6mo |
| AMERIPRISE FINANCIAL INC | QTRX Quanterix Corp | 13G/A | 7.5% | Mar 31, 2026 | 6mo |
| Venrock Healthcare Capital Partners III, L.P. | SRZN Surrozen, Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | XFOR X4 Pharmaceuticals, Inc | 13G/A | 7.3% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | WING Wingstop Inc. | 13G/A | 6.6% | Mar 31, 2026 | 6mo |
| Iroquois Capital Management, LLC | IVDA Iveda Solutions, Inc. | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| Fairbanks Jonathan B. | FLOC Flowco Holdings Inc. | 13G/A | 41.3% | Mar 31, 2026 | 6mo |
| TCG Crossover GP II, LLC | GLUE Monte Rosa Therapeutics, Inc. | 13G/A | 5.5% | Mar 31, 2026 | 6mo |
| Rubric Capital Management LP | SDGR Schrodinger, Inc. | 13G/A | 9.28% | Mar 31, 2026 | 6mo |
| First Trust Capital Management L.P. | SIMA SIM Acquisition Corp. I | 13G/A | 5.63% | Mar 31, 2026 | 6mo |
| CITADEL ADVISORS LLC | ACRV Acrivon Therapeutics, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | MYFW First Western Financial Inc | 13G | 5.3% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | STOK Stoke Therapeutics, Inc. | 13G | 5.2% | Mar 31, 2026 | 6mo |
| VAN ECK ASSOCIATES CORP | HL Hecla Mining Co | 13G/A | 5.32% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | TRGP Targa Resources Corp. | 13G/A | 7% | Mar 31, 2026 | 6mo |
| Kenneth Griffin | CORZ Core Scientific, Inc. | 13G/A | 4.1% | Mar 31, 2026 | 6mo |
| OceanLink Partners Fund, LP | HUYA HUYA Inc. | 13G/A | 8.8% | Mar 31, 2026 | 6mo |
| Dellora Investments LP | TENX Tenax Therapeutics, Inc. | 13G/A | 2.3% | Mar 31, 2026 | 6mo |
| Lan Huang | BYSI BeyondSpring Inc. | 13G/A | 14.1% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | ARTL Artelo Biosciences, Inc. | 13G | 9.99% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | TVTX Travere Therapeutics, Inc. | 13G | 5.27% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | BDCI BTC Development Corp. | 13G/A | 7.52% | Mar 31, 2026 | 6mo |
| Venrock Healthcare Capital Partners III, L.P. | ZURA Zura Bio Ltd | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| Linonia Partnership LP | GWRE Guidewire Software, Inc. | 13G/A | 9% | Mar 31, 2026 | 6mo |
| FIG LLC | NN Nextnav Inc. | 13G/A | 15.3% | Mar 31, 2026 | 6mo |
| COHEN & STEERS, INC. | ESS Essex Property Trust, Inc. | 13G/A | 7.53% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | RIGL Rigel Pharmaceuticals Inc | 13G | 6.93% | Mar 31, 2026 | 6mo |
| COHEN & STEERS, INC. | EPRT Essential Properties Realty Trust, Inc. | 13G/A | 14.16% | Mar 31, 2026 | 6mo |
| AQR CAPITAL MANAGEMENT LLC | TXRH Texas Roadhouse, Inc. | 13G | 5.49% | Mar 31, 2026 | 6mo |
| Ugur Sahin | BNTX BioNTech SE | 13G/A | 15.8% | Mar 31, 2026 | 6mo |
| Azora Capital LP | BRBS Blue Ridge Bankshares, Inc. | 13G/A | 3% | Mar 31, 2026 | 6mo |
| ROYAL BANK OF CANADA | LBRDK Liberty Broadband Corp | 13G/A | 4.62% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | CAEP Cantor Equity Partners III, Inc. | 13G/A | 9.7% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | SLMT Solmate Infrastructure PLC | 13G/A | 8.76% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | BAH Booz Allen Hamilton Holding Corp | 13G | 5.5% | Mar 31, 2026 | 6mo |
| VAN ECK ASSOCIATES CORP | SLI Standard Lithium Ltd. | 13G/A | 7.74% | Mar 31, 2026 | 6mo |
| TENOR CAPITAL MANAGEMENT Co., L.P. | CAQ Cambridge Acquisition Corp. | 13G/A | 4.3% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | DYN Dyne Therapeutics, Inc. | 13G/A | 8.3% | Mar 31, 2026 | 6mo |